Cross-reactivity of anti-PLA2R1 autoantibodies to rabbit and mouse PLA2R1 antigens and development of two novel ELISAs with different diagnostic performances in idiopathic membranous nephropathy

Biochimie

Volumn 118, Issue , 2015, Pages 104-115

  Seitz Polski, Barbara ^a,b,c   Dolla, Guillaume ^a   Payré, Christine ^a   Tomas, Nicola M ^a,d   Lochouarn, Marine ^a,b,c   Jeammet, Louise ^a   Mariat, Christophe ^e   Krummel, Thierry ^f   Burtey, Stéphane ^g   Courivaud, Cécile ^h   Schlumberger, Wolfgang ⁱ   Zorzi, Kévin ^c   Benzaken, Sylvia ^c   Bernard, Ghislaine ^c   Esnault, Vincent L M ^b   Lambeau, Gérard ^a  

^a INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b PASTEUR HOSPITAL   (France)

^c CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^e UNIVERSITÉ JEAN MONNET   (France)

^f UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^g AIX MARSEILLE UNIVERSITY   (France)

^h HÔPITAL SAINT JACQUES   (France)

ⁱ Institute of Experimental Immunology   (Germany)

Author keywords

Autoimmunity; Conformational epitope; ELISA; Membranous nephropathy; Mouse PLA2R1; Orthologs; PLA2R1 autoantibodies; Rabbit PLA2R1

Indexed keywords

AUTOANTIBODY; EPITOPE; PHOSPHOLIPASE A2 RECEPTOR; PLA2R1 AUTOANTIBODY; UNCLASSIFIED DRUG; AUTOANTIGEN; PLA2R1 PROTEIN, HUMAN; PLA2R1 PROTEIN, MOUSE;

ADULT; AGED; ANTIGEN SPECIFICITY; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IDIOPATHIC DISEASE; IDIOPATHIC MEMBRANOUS NEPHROPATHY; MAJOR CLINICAL STUDY; MALE; MEMBRANOUS GLOMERULONEPHRITIS; MOUSE; NONHUMAN; ORTHOLOGY; OUTCOME ASSESSMENT; PATIENT RISK; PROGNOSIS; RABBIT; RECEIVER OPERATING CHARACTERISTIC; REMISSION; SPECIES DIFFERENCE; TASK PERFORMANCE; WESTERN BLOTTING; ANIMAL; GLOMERULONEPHRITIS, MEMBRANOUS; IMMUNOLOGY; PROCEDURES;

ANIMALS; AUTOANTIBODIES; AUTOANTIGENS; BLOTTING, WESTERN; CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; RABBITS; RECEPTORS, PHOSPHOLIPASE A2;

EID: 84941140714     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2015.08.007     Document Type: Article

References (38)

1. L.H. Beck Jr., and D.J. Salant Membranous nephropathy: recent travels and new roads ahead Kidney Int. 77 2010 765 770
2. P. Ronco, and H. Debiec Pathogenesis of membranous nephropathy: recent advances and future challenges Nat. Rev. Nephrol. 8 2012 203 213
3. J.M. Hofstra, F.C. Fervenza, and J.F. Wetzels Treatment of idiopathic membranous nephropathy Nat. Rev. Nephrol. 9 2013 443 458
4. C. Ponticelli, and R.J. Glassock Glomerular diseases: membranous nephropathy-a modern view Clin. J. Am. Soc. Nephrol. 9 2014 609 616
5. L.H. Beck Jr., and D.J. Salant Membranous nephropathy: from models to man J. Clin. Invest. 124 2014 2307 2314
6. G. Remuzzi, C. Chiurchiu, M. Abbate, V. Brusegan, M. Bontempelli, and P. Ruggenenti Rituximab for idiopathic membranous nephropathy Lancet 360 2002 923 924
7. J. Radhakrishnan, and D.C. Cattran The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines-application to the individual patient Kidney Int. 82 2012 840 856
8. L.H. Beck Jr., R.G. Bonegio, G. Lambeau, D.M. Beck, D.W. Powell, T.D. Cummins, J.B. Klein, and D.J. Salant M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy N. Engl. J. Med. 361 2009 11 21
9. W. Qin, L.H. Beck Jr., C. Zeng, Z. Chen, S. Li, K. Zuo, D.J. Salant, and Z. Liu Anti-phospholipase A2 receptor antibody in membranous nephropathy J. Am. Soc. Nephrol. 22 2011 1137 1143
10. J.M. Hofstra, L.H. Beck Jr., D.M. Beck, J.F. Wetzels, and D.J. Salant Anti-phospholipase A2 receptor antibodies correlate with clinical status in idiopathic membranous nephropathy Clin. J. Am. Soc. Nephrol. 6 2011 1286 1291
11. C. Murtas, M. Bruschi, G. Candiano, G. Moroni, R. Magistroni, A. Magnano, F. Bruno, A. Radice, L. Furci, L. Argentiero, M.L. Carnevali, P. Messa, F. Scolari, R.A. Sinico, L. Gesualdo, F.C. Fervenza, L. Allegri, P. Ravani, and G.M. Ghiggeri Coexistence of different circulating anti-podocyte antibodies in membranous nephropathy Clin. J. Am. Soc. Nephrol. 7 2012 1394 1400
12. E. Hoxha, U. Kneissler, G. Stege, G. Zahner, I. Thiele, U. Panzer, S. Harendza, U.M. Helmchen, and R.A. Stahl Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy Kidney Int. 82 2012 797 804
13. J.M. Hofstra, H. Debiec, C.D. Short, T. Pelle, R. Kleta, P.W. Mathieson, P. Ronco, P.E. Brenchley, and J.F. Wetzels Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy J. Am. Soc. Nephrol. 23 2012 1735 1743
14. C. Dahnrich, L. Komorowski, C. Probst, B. Seitz-Polski, V. Esnault, J.F. Wetzels, J.M. Hofstra, E. Hoxha, R.A. Stahl, G. Lambeau, W. Stocker, and W. Schlumberger Development of a standardized ELISA for the determination of autoantibodies against human M-type phospholipase A2 receptor in primary membranous nephropathy Clin. Chim. Acta 421C 2013 213 218
15. Y.J. Oh, S.H. Yang, D.K. Kim, S.W. Kang, and Y.S. Kim Autoantibodies against phospholipase A2 receptor in Korean patients with membranous nephropathy PloS one 8 2013 e62151
16. D. Kanigicherla, J. Gummadova, E.A. McKenzie, S.A. Roberts, S. Harris, M. Nikam, K. Poulton, L. McWilliam, C.D. Short, M. Venning, and P.E. Brenchley Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy Kidney Int. 83 2013 940 948
17. S. Akiyama, M. Akiyama, E. Imai, T. Ozaki, S. Matsuo, and S. Maruyama Prevalence of anti-phospholipase A2 receptor antibodies in Japanese patients with membranous nephropathy Clin. Exp, Nephrol. 19 2015 653 660
18. L.H. Beck Jr., F.C. Fervenza, D.M. Beck, R.G. Bonegio, F.A. Malik, S.B. Erickson, F.G. Cosio, D.C. Cattran, and D.J. Salant Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy J. Am. Soc. Nephrol. 22 2011 1543 1550
19. E. Hoxha, I. Thiele, G. Zahner, U. Panzer, S. Harendza, and R.A. Stahl Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy J. Am. Soc. Nephrol. 25 2014 1357 1366
20. A.P. Bech, J.M. Hofstra, P.E. Brenchley, and J.F. Wetzels Association of anti-PLA2R antibodies with outcomes after immunosuppressive therapy in idiopathic membranous nephropathy Clin. J. Am. Soc. Nephrol. 9 2014 1386 1392
21. B. Seitz-Polski, C. Payre, D. Ambrosetti, L. Albano, E. Cassuto-Viguier, M. Berguignat, A. Jeribi, M.C. Thouret, G. Bernard, S. Benzaken, G. Lambeau, and V.L. Esnault Prediction of membranous nephropathy recurrence after transplantation by monitoring of anti-PLA2R1 (M-type phospholipase A2 receptor) autoantibodies: a case series of 15 patients Nephrol. Dial. Transpl. 29 2014 2334 2342
22. G. Lambeau, and M. Lazdunski Receptors for a growing family of secreted phospholipases A2 Trends Pharmacol. Sci. 20 1999 162 170
23. E. Hoxha, S. Harendza, G. Zahner, U. Panzer, O. Steinmetz, K. Fechner, U. Helmchen, and R.A. Stahl An immunofluorescence test for phospholipase-A2-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis Nephrol. Dial. Transpl. 26 2011 2526 2532
24. A. Behnert, M. Schiffer, J. Muller-Deile, L.H. Beck Jr., M. Mahler, and M.J. Fritzler Antiphospholipase A(2) receptor autoantibodies: a comparison of three different immunoassays for the diagnosis of idiopathic membranous nephropathy J. Immunol. Res. 2014 2014 143274
25. P. Ancian, G. Lambeau, M.G. Mattéi, and M. Lazdunski The human 180-kDa receptor for secretory phospholipases A2. Molecular cloning, identification of a secreted soluble form, expression, and chromosomal localization, J. Biol. Chem. 270 1995 8963 8970
26. G. Lambeau, P. Ancian, J. Barhanin, and M. Lazdunski Cloning and expression of a membrane receptor for secretory phospholipases A2 J. Biol. Chem. 269 1994 1575 1578
27. M. Rouault, C. Le Calvez, E. Boilard, F. Surrel, A. Singer, F. Ghomashchi, S. Bezzine, S. Scarzello, J. Bollinger, M.H. Gelb, and G. Lambeau Recombinant production and properties of binding of the full set of mouse secreted phospholipases A2 to the mouse M-type receptor Biochemistry 46 2007 1647 1662
28. E. Zvaritch, G. Lambeau, and M. Lazdunski Endocytic properties of the M-type 180-kDa receptor for secretory phospholipases A2 J. Biol. Chem. 271 1996 250 257
29. L. Kao, V. Lam, M. Waldman, R.J. Glassock, and Q. Zhu Identification of the immunodominant epitope region in phospholipase A2 receptor-mediating autoantibody binding in idiopathic membranous nephropathy J. Am. Soc. Nephrol.: JASN 26 2015 291 301
30. M. Fresquet, T.A. Jowitt, J. Gummadova, R. Collins, R. O'Cualain, E.A. McKenzie, R. Lennon, and P.E. Brenchley Identification of a major epitope recognized by PLA2R autoantibodies in primary membranous nephropathy J. Am. Soc. Nephrol.: JASN 26 2015 302 313
31. P.A. Michel, K. Dahan, P.Y. Ancel, E. Plaisier, R. Mojaat, S. De Seigneux, E. Daugas, M. Matignon, L. Mesnard, A. Karras, H. Francois, A. Pardon, V. Caudwell, H. Debiec, and P. Ronco Rituximab treatment for membranous nephropathy: a French clinical and serological retrospective study of 28 patients Nephron Extra 1 2011 251 261
32. A. Segarra-Medrano, E. Jatem-Escalante, C. Carnicer-Caceres, I. Agraz-Pamplona, M.T. Salcedo, N. Valtierra, E. Ostos-Roldan, K.V. Arredondo, and J. Jaramillo Evolution of antibody titre against the M-type phospholipase A2 receptor and clinical response in idiopathic membranous nephropathy patients treated with tacrolimus Nefrologia 34 2014 491 497
33. P. Ruggenenti, H. Debiec, B. Ruggiero, A. Chianca, T. Pelle, F. Gaspari, F. Suardi, E. Gagliardini, S. Orisio, A. Benigni, P. Ronco, and G. Remuzzi Anti-Phospholipase A2 Receptor antibody titer predicts post-rituximab outcome of membranous nephropathy J. Am. Soc. Nephrol.: JASN 2015
34. A. Augert, D. Vindrieux, C.A. Girard, B. Le Calve, B. Gras, M. Ferrand, B.P. Bouchet, A. Puisieux, Y. de Launoit, H. Simonnet, G. Lambeau, and D. Bernard PLA2R1 kills cancer cells by inducing mitochondrial stress Free Radic. Biol. Med. 65C 2013 969 977
35. A. Augert, C. Payré, Y. de Launoit, J. Gil, G. Lambeau, and D. Bernard The M-type receptor PLA2R regulates senescence through the p53 pathway EMBO Rep. 10 2009 271 277
36. C. Murtas, L. Allegri, and G.M. Ghiggeri Circulating antipodocyte antibodies in membranous nephropathy: new findings Am. J. Kidney Dis. 62 2013 12 15
37. C.P. Larsen, N.C. Messias, F.G. Silva, E. Messias, and P.D. Walker Determination of primary versus secondary membranous glomerulopathy utilizing phospholipase A2 receptor staining in renal biopsies Mod. Pathol. 26 2013 709 715
38. A. Behnert, M.J. Fritzler, B. Teng, M. Zhang, F. Bollig, H. Haller, A. Skoberne, M. Mahler, and M. Schiffer An anti-phospholipase A2 receptor quantitative immunoassay and epitope analysis in membranous nephropathy reveals different antigenic domains of the receptor PloS one 8 2013 e61669